CDT Equity (CDT) Research & Development (2022 - 2026)

CDT Equity (CDT) has reported Research & Development for 4 consecutive years, with $302000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 83.76% year-over-year to $302000.0; the trailing twelve-month figure through Jun 2026 stood at $3.4 million (down 44.04% YoY), and the FY2025 full-year result was $5.1 million, up 49.62% from the prior year.
• Research & Development retreated to $302000.0 in Q2 2026 per CDT's latest filing, from $778000.0 in the prior quarter.
• Across five years, Research & Development topped out at $3.1 million in Q3 2024 and bottomed at -$1000.0 in Q4 2022.
• Historically, Research & Development has averaged $795750.0 across 4 years, with a median of $524000.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Research & Development jumped 7340.0% in 2025, then plunged 83.76% in 2026.
• Over 4 years, Research & Development stood at -$1000.0 in 2022, then jumped by 13300.0% to $132000.0 in 2024, then soared by 465.15% to $746000.0 in 2025, then tumbled by 59.52% to $302000.0 in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $302000.0, $778000.0, and $746000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.